Orthopedic & Footcare Products ישראל - עברית - Ministry of Health

orthopedic & footcare products

דין דיאגנוסטיקה בע"מ - כלל האוכלוסיה

פוטאן קרם ישראל - עברית - Ministry of Health

פוטאן קרם

אס.טי. הלתליין בעמ - קרם לכף הרגל

טרובלט 50 מ"ג ישראל - עברית - Ministry of Health

טרובלט 50 מ"ג

glaxo smith kline (israel) ltd - retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

טרובלט 50 מ"ג , טרובלט 100 מ"ג ישראל - עברית - Ministry of Health

טרובלט 50 מ"ג , טרובלט 100 מ"ג

glaxo smith kline (israel) ltd - retigabine 100 mg; retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

טרובלט 100 מ"ג ישראל - עברית - Ministry of Health

טרובלט 100 מ"ג

glaxo smith kline (israel) ltd - retigabine 100 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

טרובלט 300 מ"ג ישראל - עברית - Ministry of Health

טרובלט 300 מ"ג

glaxo smith kline (israel) ltd - retigabine 300 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

טרובלט 400 מ"ג ישראל - עברית - Ministry of Health

טרובלט 400 מ"ג

glaxo smith kline (israel) ltd - retigabine 400 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.